{"id":59612,"date":"2026-05-10T00:12:42","date_gmt":"2026-05-10T00:12:42","guid":{"rendered":"https:\/\/tpumedical.com\/?p=59612"},"modified":"2026-05-10T00:14:59","modified_gmt":"2026-05-10T00:14:59","slug":"case-study-how-our-medical-grade-tpu-film-reduced-device-failure-rates-by-30-for-a-major-oem","status":"publish","type":"post","link":"https:\/\/tpumedical.com\/es\/case-study-how-our-medical-grade-tpu-film-reduced-device-failure-rates-by-30-for-a-major-oem\/","title":{"rendered":"Case Study: How Our Medical-Grade TPU Film Reduced Device Failure Rates by 30% for a Major OEM"},"content":{"rendered":"

This case study details a successful technical collaboration between a Fortune 500 global Original Equipment Manufacturer (OEM) of sequential compression devices (SCDs). The OEM faced persistent field failures and rising warranty costs due to inflatable bladder ruptures in their reusable therapeutic sleeves. By replacing their incumbent plasticized PVC film with our proprietary\u00a00.20 mm MediFusion\u2122 MX202 Medical-Grade TPU Film<\/strong>, the OEM achieved a\u00a030% reduction in device failure rates<\/strong>\u00a0within 12 months of full implementation. This resulted in over $2 million in annual warranty savings, improved patient therapy continuity, and strengthened brand reputation. This document outlines the technical challenge, our material solution, rigorous validation process, and quantified business outcomes.<\/p>\n\n\n\n

Client Background & Industry Challenge<\/h3>\n\n\n\n

The Client<\/strong>
A Fortune 500 medical technology company and global market leader in vascular therapy and compression devices. Their flagship SCDs are used in hospitals worldwide for the prevention of deep vein thrombosis (DVT) and management of lymphedema \u2014 operating 24\/7 in critical care environments.<\/p>\n\n\n\n

The Core Problem<\/strong>
The client experienced an unacceptable failure rate in the inflatable bladders of their reusable gradient compression sleeves. Failures included sudden ruptures and chronic micro-leaks, leading to:<\/p>\n\n\n\n

    \n
  • Therapy disruption<\/strong> \u2013 Devices stopped working, increasing DVT risk for patients.<\/li>\n\n\n\n
  • High field repair\/replacement costs<\/strong> \u2013 Warranty claims spiked across multiple hospital accounts.<\/li>\n\n\n\n
  • Customer (hospital) dissatisfaction<\/strong> \u2013 Negative feedback damaged the OEM\u2019s reputation for reliability.<\/li>\n\n\n\n
  • Increased internal investigation costs<\/strong> \u2013 Engineering and QA teams diverted significant resources to failure analysis.<\/li>\n<\/ul>\n\n\n\n

    Preliminary Root Cause Analysis<\/strong>
    The client\u2019s internal investigation identified the plasticized PVC film as the primary contributor. Specific failure modes:<\/p>\n\n\n\n

    Failure Mode<\/th>Description<\/th><\/tr><\/thead>
    Cracking at HF-welded seams<\/strong><\/td>Welds became brittle and cracked after repeated inflation cycles.<\/td><\/tr>
    Pinholes & micro-tears<\/strong><\/td>Microscopic perforations developed from folding, cleaning, and pressure cycling.<\/td><\/tr>
    Material fatigue<\/strong><\/td>PVC lost elasticity over the device\u2019s intended lifespan (hundreds of cycles), unable to sustain inflation pressure.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
    \n

    Plasticized PVC also posed long-term regulatory risks due to phthalate content, though not the immediate driver.<\/p>\n<\/blockquote>\n\n\n\n

    Solution: Proprietary Medical-Grade TPU Film<\/h3>\n\n\n\n

    The client initiated a formal supplier qualification process. We was selected as the development partner based on proven expertise in medical-grade polymers and a track record of solving similar application challenges.<\/p>\n\n\n\n

    A. Material Specification Analysis<\/h4>\n\n\n\n

    Our engineering team collaborated directly with the client to define exact requirements:<\/p>\n\n\n\n

    Parameter<\/th>Requirement<\/th><\/tr><\/thead>
    Pressure cycling<\/strong><\/td>Multiple inflation\/deflation cycles per minute, up to 24 hours\/day<\/td><\/tr>
    Cleaning protocols<\/strong><\/td>Repeated wipe-downs and immersion in hospital-grade disinfectants (alcohol, oxidative agents)<\/td><\/tr>
    Mechanical stress<\/strong><\/td>Folding, wrapping, compression, and incidental impacts<\/td><\/tr>
    Biocompatibility<\/strong><\/td>Long-term surface contact (ISO 10993)<\/td><\/tr>
    Process compatibility<\/strong><\/td>High-frequency (HF) welding on existing production lines<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

    B. Proposed Solution<\/h4>\n\n\n\n

    We recommended MediFusion\u2122 MX202 Medical-Grade TPU Film \u2013 0.20 mm thickness<\/strong>, selected for the following material properties:<\/p>\n\n\n\n

    Property<\/th>Benefit<\/th><\/tr><\/thead>
    Superior fatigue resistance & elastic recovery<\/strong><\/td>TPU\u2019s molecular structure withstands millions of flex\/pressure cycles without micro-cracks or permanent set \u2014 directly solving PVC material fatigue.<\/td><\/tr>
    Enhanced HF weld strength<\/strong><\/td>Molecular-level fusion creates welds as strong or stronger than the base material, eliminating seam cracking.<\/td><\/tr>
    Excellent chemical & hydrolytic stability<\/strong><\/td>Resists degradation from alcohols, oxidizers, and repeated washing \u2014 no embrittlement over time.<\/td><\/tr>
    High purity & biocompatibility<\/strong><\/td>Phthalate-free, manufactured from pharmaceutical-grade raw materials. Full ISO 10993 test reports included (cytotoxicity, sensitization, irritation).<\/td><\/tr>
    Precise dimensional control<\/strong><\/td>0.20 mm optimized for flexibility (patient limb conformance) and durability (puncture\/tear resistance).<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

    Validation & Testing Process<\/h3>\n\n\n\n

    The client required rigorous, data-driven validation before any material change. We supported a three-phase protocol.<\/p>\n\n\n\n

    Phase 1: Laboratory Benchmark Testing<\/h4>\n\n\n\n

    We supplied film samples to the client\u2019s internal lab and an accredited third-party lab.<\/p>\n\n\n\n

    Results (TPU vs. incumbent PVC):<\/strong><\/p>\n\n\n\n

    Property<\/th>Improvement<\/th><\/tr><\/thead>
    Tear strength<\/td>+45%<\/strong><\/td><\/tr>
    Elongation at break<\/td>+120%<\/strong><\/td><\/tr>
    Peel strength (welded seam)<\/td>+60%<\/strong><\/td><\/tr>
    Accelerated aging (equivalent 2 years)<\/td>TPU: <2% degradation; PVC: >25% loss in flexibility<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

    Phase 2: Process Validation (HF Welding)<\/h4>\n\n\n\n

    A key challenge was compatibility with existing production equipment. Our engineers visited the client\u2019s manufacturing site to co-optimize welding parameters (power, pressure, dwell time, cooling).<\/p>\n\n\n\n

    Results:<\/strong><\/p>\n\n\n\n

      \n
    • Achieved strong, consistent, defect-free welds across multiple production lines.<\/li>\n\n\n\n
    • Burst pressure tests on welded seams: TPU seams failed at 35% higher pressure<\/strong> than PVC seams.<\/li>\n\n\n\n
    • Critical observation: TPU failure mode was substrate tear<\/strong> (away from weld), whereas PVC failed at the weld interface<\/strong>.<\/li>\n<\/ul>\n\n\n\n

      Phase 3: Prototyping & Field Trial<\/h4>\n\n\n\n

      The client produced limited-run sleeves using our TPU film and deployed them in a controlled 6-month field trial across three high-volume hospitals.<\/p>\n\n\n\n

      Results:<\/strong><\/p>\n\n\n\n

        \n
      • Zero material-related failures<\/strong> in the TPU group (n=1,200 sleeves).<\/li>\n\n\n\n
      • Control group (incumbent PVC) showed expected failure rate of ~3.5%.<\/li>\n\n\n\n
      • Hospital staff feedback: TPU sleeves felt \u201cmore durable, flexible, and easier to clean.\u201d<\/li>\n<\/ul>\n\n\n\n

        Implementation & Quantified Outcomes<\/h3>\n\n\n\n

        Based on the validation data, the client approved full transition to MediFusion\u2122 MX202 TPU film<\/strong> for all new production and as a replacement bladder in service kits.<\/p>\n\n\n\n

        Quantified Results (12 months post-implementation)<\/h4>\n\n\n\n
        KPI<\/th>Result<\/th><\/tr><\/thead>
        Field failure rate reduction<\/strong><\/td>\u219330%<\/strong> (from 3.5% to 2.45% of warranty returns)<\/td><\/tr>
        Annual warranty cost savings<\/strong><\/td>$2.1 million<\/strong> (direct costs only; excludes logistics and brand impact)<\/td><\/tr>
        Production scrap rate reduction<\/strong><\/td>\u219315%<\/strong> (fewer failed welds during manufacturing)<\/td><\/tr>
        Customer complaints (related to bladders)<\/strong><\/td>\u219352%<\/strong><\/td><\/tr>
        Return on investment (ROI)<\/strong><\/td>Achieved within 8 months<\/strong> of full implementation<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

        Additional Business Benefits<\/h4>\n\n\n\n
          \n
        • Improved patient therapy continuity<\/strong> \u2013 Fewer device swaps during critical DVT prevention.<\/li>\n\n\n\n
        • Stronger brand reputation<\/strong> \u2013 OEM launched \u201cenhanced durability\u201d messaging as a competitive differentiator.<\/li>\n\n\n\n
        • Regulatory readiness<\/strong> \u2013 TPU\u2019s phthalate-free composition aligns with EU MDR and future global restrictions.<\/li>\n<\/ul>\n\n\n\n

          Lessons Learned & Future Outlook<\/h3>\n\n\n\n

          This case study demonstrates that in medical device design, material selection is not a commodity decision \u2014 it is a critical performance and risk-management decision<\/strong>.<\/p>\n\n\n\n

          Key Success Factors<\/h4>\n\n\n\n
            \n
          • Collaborative problem-solving<\/strong> \u2013 We operated as an extension of the client\u2019s engineering team, not just a material supplier.<\/li>\n\n\n\n
          • Data-driven validation<\/strong> \u2013 Every phase (lab, process, field) was backed by objective, auditable data.<\/li>\n\n\n\n
          • Support beyond the product<\/strong> \u2013 We provided technical expertise, on-site process optimization, and complete regulatory documentation (ISO 10993, material master files, welding guides).<\/li>\n<\/ul>\n\n\n\n

            Looking Forward<\/h4>\n\n\n\n

            The success of this project has opened broader collaboration opportunities:<\/p>\n\n\n\n

              \n
            • The client is now evaluating our Tejidos recubiertos de TPU<\/strong> for reusable blood pressure cuffs and inflatable splints \u2014 targeting similar reliability and cost benefits.<\/li>\n\n\n\n
            • Initial discussions are underway to qualify our TPU film for single-use SCD sleeves<\/strong> to reduce hospital waste while maintaining performance.<\/li>\n<\/ul>\n\n\n\n

              Choosing our medical-grade TPU materials is not merely a supplier change \u2014 it is a strategic investment in device performance, regulatory security, and long-term brand equity<\/p>\n\n\n\n

              Ready to reduce your device failure rates?<\/strong> Contact us to request samples, welding support, or a customized validation plan.<\/p>","protected":false},"excerpt":{"rendered":"

              This case study details a successful technical collaboration between a Fortune 500 global Original Equipment Manufacturer (OEM) of sequential compression devices (SCDs). The OEM faced persistent field failures and rising…<\/p>","protected":false},"author":1,"featured_media":59518,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[227],"tags":[],"class_list":["post-59612","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-quality-compliance"],"acf":[],"_links":{"self":[{"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/posts\/59612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/comments?post=59612"}],"version-history":[{"count":2,"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/posts\/59612\/revisions"}],"predecessor-version":[{"id":59615,"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/posts\/59612\/revisions\/59615"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/media\/59518"}],"wp:attachment":[{"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/media?parent=59612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/categories?post=59612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tpumedical.com\/es\/wp-json\/wp\/v2\/tags?post=59612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}